Mauripharm Limited - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 03120490 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2021

FOR

MAURIPHARM LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

A C Kureeman

REGISTERED OFFICE:

224 Barnett Wood Lane

Ashstead

Surrey

KT21 2DB

REGISTERED NUMBER:

03120490 (England and Wales)

ACCOUNTANTS:

Romsey Accountants GDT Limited

Chartered Accountants

Unit 3, Shelley Farm

Shelley Lane

Ower

Romsey

Hampshire

SO51 6AS

FIXED ASSETS

Intangible assets

4

-

-

Tangible assets

5

76,299

542,526

Investments

6

7,763

7,763

84,062

550,289

CURRENT ASSETS

Stocks

101,269

92,129

Debtors

7

1,172,334

491,654

Cash at bank and in hand

110,515

192,546

1,384,118

776,329

CREDITORS

Amounts falling due within one year

8

491,159

466,205

NET CURRENT ASSETS

892,959

310,124

TOTAL ASSETS LESS CURRENT LIABILITIES

977,021

860,413

CREDITORS

Amounts falling due after more than one year

9

125,647

189,948

NET ASSETS

851,374

670,465

CAPITAL AND RESERVES

Called up share capital

200

200

Revaluation reserve

10

-

86,854

Retained earnings

851,174

583,411

SHAREHOLDERS' FUNDS

851,374

670,465

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2021 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 2 March 2022 and were signed by:

A C Kureeman - Director

1.	STATUTORY INFORMATION

Mauripharm Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 1998, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Land and buildings

-

2% on cost

Plant and machinery etc

-

25% on cost and 20% on reducing balance

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 16 (2020 - 16 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 December 2020

and 30 November 2021

136,000

AMORTISATION

At 1 December 2020

and 30 November 2021

136,000

NET BOOK VALUE

At 30 November 2021

-

At 30 November 2020

-

5.	TANGIBLE FIXED ASSETS

Plant and

Land and

machinery

buildings

etc

Totals

£

£

£

COST

At 1 December 2020

684,969

132,796

817,765

Additions

-

482

482

Disposals

(544,969

)

-

(544,969

)

At 30 November 2021

140,000

133,278

273,278

DEPRECIATION

At 1 December 2020

154,028

121,211

275,239

Charge for year

2,800

2,501

5,301

Eliminated on disposal

(83,561

)

-

(83,561

)

At 30 November 2021

73,267

123,712

196,979

NET BOOK VALUE

At 30 November 2021

66,733

9,566

76,299

At 30 November 2020

530,941

11,585

542,526

6.	FIXED ASSET INVESTMENTS

Other

investments

£

COST

At 1 December 2020

and 30 November 2021

7,763

NET BOOK VALUE

At 30 November 2021

7,763

At 30 November 2020

7,763

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.11.21

30.11.20

£

£

Trade debtors

490,870

448,019

Amounts owed by associates

550,000

-

Other debtors

131,464

43,635

1,172,334

491,654

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.11.21

30.11.20

£

£

Trade creditors

412,312

381,857

Taxation and social security

74,010

72,037

Other creditors

4,837

12,311

491,159

466,205

9.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

30.11.21

30.11.20

£

£

Bank loans

125,647

189,948

Amounts falling due in more than five years:

Repayable by instalments

Bank loans more 5 yr by instal

125,647

189,948

10.

RESERVES

Revaluation

reserve

£

At 1 December 2020

86,854

Write off revaluation

(86,854

)

At 30 November 2021

-

11.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the year ended 30 November 2021 and the period ended 30 November 2020:

30.11.21

30.11.20

£

£

A C Kureeman

Balance outstanding at start of year

(1,591

)

(51,824

)

Amounts advanced

55,225

57,233

Amounts repaid

(46,950

)

(7,000

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

6,684

(1,591

)